Faculty Bibliography

OBJECTIVE:To determine the frequency of magnetic resonance imaging (MRI) findings of ischiofemoral impingement (IFI) in patients with inflammatory myositis (IM) and associated factors. METHODS:Pelvis and thigh MRI studies of 314 consecutive patients (57% women; mean age, 55.5 years; range, 18-85) with suspected muscle disease were reviewed. RESULTS:Ischiofemoral impingement at MRI was present in 11% of patients with a final diagnosis of IM and in 2% of patients with an alternative diagnosis (P = 0.008). In multiple logistic regression analysis, IM, but not age or sex, was independently associated with IFI at MRI (odds ratio, 5.18; 95% confidence interval, 1.19-22.6; P = 0.028). Fatty atrophy of hip stabilizing muscles was independently associated with IFI at MRI (odds ratio per unit increase of fatty atrophy score, 1.03; 95% confidence interval, 1.01-1.05; P = 0.0007). CONCLUSIONS:Magnetic resonance imaging findings of IFI are present in 11% of IM patients and are independently associated with fatty atrophy of hip stabilizing muscles.

OBJECTIVE:The aim of this study was to optimize computed tomography (CT) surveillance of skeletal metastases in patients with breast cancer through the use of osseous subtraction maps between baseline and follow-up examinations created by a novel software algorithm. The new postprocessing algorithm segments the original bone followed by image intensity-based rigid alignment creating gray-shaded maps that highlight focal or diffuse loss or increase in bone attenuation. MATERIALS AND METHODS:Institutional review board was obtained for this retrospective data evaluation. A total of 33 consecutive patients (31 female; 2 male; mean age, 59.13 ± 12.68 years; range, 32-81 years) with breast cancer were included, who underwent 143 standardized baseline and follow-up CT examinations between February 2014 and June 2016. We classified bone metastases into lytic, sclerotic, and mixed osseous lesions. Any new osteolysis inside a known sclerotic lesion and enlargement of pre-existing sclerotic lesions were considered to represent progressive disease (PD), whereas no change was classified as stable disease (SD). Results were compared additionally with the course of the disease considering the entire skeleton and other involved organs. Software-created automated bone subtraction maps were compared with conventional CT interpretations of axial 5-mm and coronal 1-mm reformatted images. Region of interest measurements were used to quantify new lesions. Results were validated by clinical and CT follow-up. Reading time was evaluated. RESULTS:Skeletal metastases were present in 17/33 (51%) patients (9 sclerotic, 2 lytic, 6 mixed) at baseline. The use of bone subtraction maps resulted in an overall change of response classification into PD in 9/33 (8.1%) patients. Compared with conventional CT evaluation, the bone subtraction maps disclosed 123 new or enlarging sclerotic and 32 new lytic metastases in 23/33 (30.9%) examinations. Mean attenuation of new bone lesions (sclerotic or lytic) significantly increased or decreased (P < 0.01) in all patients. Bone attenuation in pelvic areas without evident metastatic disease significantly increased in patients with PD (P = 0.019), whereas there was no change in SD (P = 0.076). Lesion-based sensitivity, specificity, accuracy, positive predictive values, and negative predictive values were 98.7%, 79.5%, 94.5%, 95.1%, and 94.5%, respectively. Interobserver agreement was good (κ = 0.80; P = 0.077). Reading time was significantly faster for the bone subtraction maps versus 5-mm axial images (P < 0.001). CONCLUSIONS:Longitudinal bone subtraction maps increase the accuracy and efficiency of CT diagnosis of skeletal metastases in patients with breast cancer.

INTRODUCTION/BACKGROUND:Multiple myeloma is a malignant hematological disorder of the mature B-cell lymphocytes originating in the bone marrow. While therapy monitoring is still mainly based on laboratory biomarkers, the additional use of imaging has been advocated due to inaccuracies of serological biomarkers or in a-secretory myelomas. Non-enhanced CT and MRI have similar sensitivities for lesions in yellow marrow-rich bone marrow cavities with a favourable risk and cost-effectiveness profile of CT. Nevertheless, these methods are still limited by frequently high numbers of medullary lesions and its time consumption for proper evaluation. OBJECTIVE:To establish simplified response criteria by correlating size and CT attenuation changes of medullary multiple myeloma lesions in the appendicular skeleton with the course of lytic bone lesions in the entire skeleton. Furthermore to evaluate these criteria with respect to established hematological myeloma-specific parameters for the prediction of treatment response to bortezomib or lenalidomide. MATERIALS AND METHODS/METHODS:). RESULTS:=0.54; p<0.0001). The evaluation of simplified response criteria with a measurement of only 2 medullary lesions yielded the best sensitivity and specificity valued for treatment-induced changes for the length diameter evaluation with 94.4%/95.7% for prediction of progressive disease and 78.6%/93.3% for prediction of therapy response. There were no significant differences between patients treated with bortezomib and lenalidomide (p>0.05). CONCLUSION/CONCLUSIONS:Measurements of size of a minimum of two medullary lesions is sufficient for response assessment and correlates very well with the course of lytic bone lesions and that of hematologic parameters.

OBJECTIVE:The aim of this study was to prospectively test the hypothesis that a 2-dimensional (2D) CAIPIRINHA (controlled aliasing in parallel imaging results in higher acceleration) sampling pattern facilitates 5-minute high spatial resolution 3-dimensional (3D) sampling perfection with application optimized contrast using different flip angle evolutions (SPACE) magnetic resonance imaging (MRI) of the knee with image quality similar or better than current 2D turbo spin echo (TSE) and 3D SPACE standards. MATERIALS AND METHODS:The study was approved by our institutional review board. Twenty asymptomatic subjects (12 men, 8 women; mean age, 42 years; age range, 24-65 years) underwent 3 T MRI of the knee. A 4-fold accelerated 3D SPACE TSE prototype with 2D CAIPIRINHA sampling pattern and 5-minute acquisition time was compared with commercially available 2-fold and 4-fold accelerated 3D SPACE and 2D TSE pulse sequences with acquisition times of 11 minutes and 15 seconds, 6 minutes and 30 seconds, as well as 9 minutes and 48 seconds, respectively. Outcome variables included image quality, anatomic visibility, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). Statistical analysis included Friedman, repeated measures analysis of variances, and Cohen's weighted κ tests. Bonferroni-corrected P values of 0.005 and less were considered statistically significant. RESULTS:Overall, image quality, visibility of anatomic structures, SNR, and CNR of 3D CAIPIRINHA SPACE were statistically similar to 2-fold accelerated 3D SPACE and significantly better than 4-fold accelerated 3D SPACE, which exhibited degrading parallel imaging artifacts. Compared with 2.5-mm 2D TSE images, 0.5-mm 3D CAIPIRINHA SPACE images showed statistically similar good edge sharpness and very good contrast resolution, and significantly less partial volume as well as absent chemical shift and pulsatile flow artifacts. Visibility of menisci, anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, and lateral collateral ligament was good to very good on 0.5-mm 3D CAIPIRINHA SPACE images as compared with good on 2.5-mm 2D TSE image (P < 0.005). The SNR of fat, fluid, and cartilage as well as CNR between cartilage, fluid, fat, posterior cruciate ligament, and menisci were minimally higher on 2.5-mm 2D TSE image (P < 0.005). Image quality, visibility of anatomic structures, SNR, and CNR of 2.5-mm 3D CAIPIRINHA SPACE and 2.5-mm 2D TSE images were good to very good without significant differences. CONCLUSIONS:Three-dimensional SPACE with 2D CAIPIRINHA sampling pattern enables high-quality 3D TSE MRI of the knee at an acquisition time of 5 minutes and image quality, visibility of anatomic structures, SNR, and CNR similar to conventional 3D SPACE and 2D TSE, both of which require approximately 10-minute acquisition times.

OBJECTIVE:Compressed sensing (CS) acceleration has been theorized for slice encoding for metal artifact correction (SEMAC), but has not been shown to be feasible. Therefore, we tested the hypothesis that CS-SEMAC is feasible for MRI of metal-on-metal hip resurfacing implants. MATERIALS AND METHODS/METHODS:Following prospective institutional review board approval, 22 subjects with metal-on-metal hip resurfacing implants underwent 1.5 T MRI. We compared CS-SEMAC prototype, high-bandwidth TSE, and SEMAC sequences with acquisition times of 4-5, 4-5 and 10-12 min, respectively. Outcome measures included bone-implant interfaces, image quality, periprosthetic structures, artifact size, and signal- and contrast-to-noise ratios (SNR and CNR). Using Friedman, repeated measures analysis of variances, and Cohen's weighted kappa tests, Bonferroni-corrected p-values of 0.005 and less were considered statistically significant. RESULTS:There was no statistical difference of outcomes measures of SEMAC and CS-SEMAC images. Visibility of implant-bone interfaces and pseudocapsule as well as fat suppression and metal reduction were "adequate" to "good" on CS-SEMAC and "non-diagnostic" to "adequate" on high-BW TSE (p < 0.001, respectively). SEMAC and CS-SEMAC showed mild blur and ripple artifacts. The metal artifact size was 63 % larger for high-BW TSE as compared to SEMAC and CS-SEMAC (p < 0.0001, respectively). CNRs were sufficiently high and statistically similar, with the exception of CNR of fluid and muscle and CNR of fluid and tendon, which were higher on intermediate-weighted high-BW TSE (p < 0.005, respectively). CONCLUSION/CONCLUSIONS:Compressed sensing acceleration enables the time-neutral use of SEMAC for MRI of metal-on-metal hip resurfacing implants when compared to high-BW TSE and image quality similar to conventional SEMAC.

OBJECTIVE:The aim of this study was to prospectively test the hypothesis that a compressed sensing-based slice encoding for metal artifact correction (SEMAC) turbo spin echo (TSE) pulse sequence prototype facilitates high-resolution metal artifact reduction magnetic resonance imaging (MRI) of cobalt-chromium knee arthroplasty implants within acquisition times of less than 5 minutes, thereby yielding better image quality than high-bandwidth (BW) TSE of similar length and similar image quality than lengthier SEMAC standard of reference pulse sequences. MATERIALS AND METHODS:This prospective study was approved by our institutional review board. Twenty asymptomatic subjects (12 men, 8 women; mean age, 56 years; age range, 44-82 years) with total knee arthroplasty implants underwent MRI of the knee using a commercially available, clinical 1.5 T MRI system. Two compressed sensing-accelerated SEMAC prototype pulse sequences with 8-fold undersampling and acquisition times of approximately 5 minutes each were compared with commercially available high-BW and SEMAC pulse sequences with acquisition times of approximately 5 minutes and 11 minutes, respectively. For each pulse sequence type, sagittal intermediate-weighted (TR, 3750-4120 milliseconds; TE, 26-28 milliseconds; voxel size, 0.5 × 0.5 × 3 mm) and short tau inversion recovery (TR, 4010 milliseconds; TE, 5.2-7.5 milliseconds; voxel size, 0.8 × 0.8 × 4 mm) were acquired. Outcome variables included image quality, display of the bone-implant interfaces and pertinent knee structures, artifact size, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). Statistical analysis included Friedman, repeated measures analysis of variances, and Cohen weighted k tests. Bonferroni-corrected P values of 0.005 and less were considered statistically significant. RESULTS:Image quality, bone-implant interfaces, anatomic structures, artifact size, SNR, and CNR parameters were statistically similar between the compressed sensing-accelerated SEMAC prototype and SEMAC commercial pulse sequences. There was mild blur on images of both SEMAC sequences when compared with high-BW images (P < 0.001), which however did not impair the assessment of knee structures. Metal artifact reduction and visibility of central knee structures and bone-implant interfaces were good to very good and significantly better on both types of SEMAC than on high-BW images (P < 0.004). All 3 pulse sequences showed peripheral structures similarly well. The implant artifact size was 46% to 51% larger on high-BW images when compared with both types of SEMAC images (P < 0.0001). Signal-to-noise ratios and CNRs of fat tissue, tendon tissue, muscle tissue, and fluid were statistically similar on intermediate-weighted MR images of all 3 pulse sequence types. On short tau inversion recovery images, the SNRs of tendon tissue and the CNRs of fat and fluid, fluid and muscle, as well as fluid and tendon were significantly higher on SEMAC and compressed sensing SEMAC images (P < 0.005, respectively). CONCLUSIONS:We accept the hypothesis that prospective compressed sensing acceleration of SEMAC is feasible for high-quality metal artifact reduction MRI of cobalt-chromium knee arthroplasty implants in less than 5 minutes and yields better quality than high-BW TSE and similarly high quality than lengthier SEMAC pulse sequences.

PURPOSE:The aim of this study was to prospectively test the hypothesis that 6-fold acceleration of a 3-dimensional (3D) turbo spin echo (TSE) magnetic resonance imaging (MRI) pulse sequence with k-space undersampling and iterative reconstruction is feasible for fast high spatial resolution MRI of the knee, while yielding similar image quality and diagnostic performance when compared with a conventional 2-dimensional (2D) TSE MRI standard. MATERIALS AND METHODS:The study was approved by the institutional review board. A 10-minute isotropic 3D TSE knee protocol consisting of accelerated intermediate-weighted (repetition time, 900 milliseconds; echo time, 29 milliseconds; voxel size, 0.5 × 0.5 × 0.5 mm; acquisition time, 4:45 minutes) and fat-saturated T2-weighted (repetition time, 900 milliseconds; echo time, 92 milliseconds; voxel size, 0.5 × 0.5 × 0.5 mm; acquisition time, 5:10 minutes) SPACE (sampling perfection with application optimized contrast using different flip angle evolutions) sequence prototypes was compared against a 20-minute 2D TSE standard protocol. The accelerated SPACE sequences were equipped with an optional variable-density poisson-disc pattern as an undersampling mask. An undersampling factor of 0.17 was chosen (6-fold acceleration compared with an acquisition with full sampling). An iterative, sensitivity encoding-type reconstruction with L1 norm-based regularization term was used. The study was performed on a 3 T MRI system using a 15-channel transmit/receive knee coil. The study groups included 15 asymptomatic volunteers and 15 patient volunteers. Quantitative and qualitative assessments were performed by 2 observers. Outcome variables included signal and contrast-to-noise ratio, image quality, and diagnostic accuracy. Qualitative and quantitative measurements were statistically analyzed using nonparametric tests. P values of less than 0.01 were considered significant. RESULTS:The signal-to-noise ratios of 2D and 3D MRI were similar with the exception of fluid, which was brighter on 2D MRI. Relevant contrast-to-noise ratios of 2D MRI were higher than 3D MRI; however, observer ratings for satisfaction, image quality, and visibility of anatomic structures were similar for 2D and 3D MRI. There was moderate to excellent interobserver (κ = 0.54-1.00) and intermethod (κ = 0.54-1.00) agreement for assessing menisci, cartilage, ligaments, cartilage, and bone. Two-dimensional and 3D MRI had similar sensitivity (100%/100%, respectively) and specificity (87%/75%, respectively) for detecting 9 meniscal tears (P = 1.00). CONCLUSIONS:We demonstrate the successful clinical implementation of 3D TSE MRI with incoherent k-space undersampling and iterative reconstruction for 6-fold accelerated high spatial resolution isotropic 3D MRI data acquisition. Our preliminary assessments suggest similar image quality and diagnostic performance of a comprehensive 10-minute 3D TSE MRI prototype protocol and 20-minute TSE MRI standard protocol.

OBJECTIVE:Perineural ganglion impar injections are used in the management of pelvic pain syndromes; however, there is no consensus regarding the optimal image guidance. Magnetic resonance imaging (MRI) provides high soft tissue contrast and the potential to directly visualize and target the ganglion. The purpose of this study was to assess the feasibility of MR-guided percutaneous perineural ganglion impar injections. MATERIALS AND METHODS/METHODS:Six MR-guided ganglion impar injections were performed in six human cadavers. Procedures were performed with a clinical 1.5-Tesla MRI system through a far lateral transgluteus approach. Ganglion impar visibility, distance from the sacrococcygeal joint, number of intermittent MRI control steps required to place the needle, target error between the intended and final needle tip location, inadvertent punctures of non-targeted vulnerable structures, injectant distribution, and procedure time were determined. RESULTS:The ganglion impar was seen on MRI in 4/6 (66 %) of cases and located 0.8 mm cephalad to 16.3 mm caudad (average 1.2 mm caudad) to the midpoint of the sacrococcygeal joint. Needle placement required an average of three MRI control steps (range, 2-6). The average target error was 2.2 ± 2.1 mm. In 6/6 cases (100 %), there was appropriate periganglionic distribution and filling of the presacrococcygeal space. No punctures of non-targeted structures occurred. The median procedure time was 20 min (range, 12-29 min). CONCLUSION/CONCLUSIONS:Interventional MRI can visualize and directly target the ganglion impar for accurate needle placement and successful periganglionic injection with the additional benefit of no ionizing radiation exposure to patient and staff. Our results support clinical evaluation.

Hereditary multiple exostoses (HME) is an autosomal dominant disorder characterized by the formation of multiple osteochondromas. Because of its superior soft tissue contrast and absence of ionizing radiation, magnetic resonance imaging is the first choice imaging technique for the evaluation of complex lesions and complications related to HME. However, multidetector computed tomography (MDCT) also can be of value in the evaluation of patients with HME, which is reviewed in this article. Topics outlined are low-dose MDCT technique, 3-dimensional visualization techniques, typical MDCT appearances, differential diagnostic considerations, and the usefulness of MDCT in the assessment of emergent and non-emergent complications related to HME, among which spinal cord compression, pneumothorax and hematothorax, pseudoaneurysms, fractures, growth disturbances, chondrosarcoma transformation, and muscular and peripheral nerve involvement.